Sangamo Therapeutics
SGMO
#8898
Rank
A$0.21 B
Marketcap
A$0.64
Share price
-0.53%
Change (1 day)
-61.02%
Change (1 year)

Market capitalization of Sangamo Therapeutics (SGMO)

Market cap: A$0.21 Billion

As of January 2026 Sangamo Therapeutics has a market cap of A$0.21 Billion. This makes Sangamo Therapeutics the world's 8898th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sangamo Therapeutics from 2000 to 2026

End of year Market Cap

Year Marketcap Change
2026A$0.21 B1.2%
2025A$0.21 B-75.14%
2024A$0.85 B507.21%
2023A$0.14 B-81.3%
2022A$0.75 B-49.82%
2021A$1.50 B-47.5%
2020A$2.87 B107.04%
2019A$1.38 B-16.74%
2018A$1.66 B-6.21%
2017A$1.77 B494.16%
2016A$0.29 B-66.11%
2015A$0.88 B-31.3%
2014A$1.28 B32.42%
2013A$0.96 B215.87%
2012A$0.30 B111.13%
2011A$0.14 B-51%
2010A$0.29 B0.04%
2009A$0.29 B46.7%
2008A$0.20 B-66.34%
2007A$0.60 B104.64%
2006A$0.29 B74.26%
2005A$0.16 B-14.07%
2004A$0.19 B6.7%
2003A$0.18 B38.93%
2002A$0.13 B-70.5%
2001A$0.44 B-41.99%
2000A$0.77 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Sangamo Therapeutics was reported to be:

A$0.21 Billion
by Nasdaq info icon info icon
A$0.21 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Gilead Sciences
GILD
A$224.39 B 103,749.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Alnylam Pharmaceuticals
ALNY
A$70.39 B 32,477.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
A$264.49 B 122,310.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
A$36.83 B 16,947.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Dow
DOW
A$29.63 B 13,617.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$788.05 B 364,615.32%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$15.78 B 7,204.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$414.00 B 191,505.99%๐Ÿ‡บ๐Ÿ‡ธ USA